Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

N-DEMETHYLERYTHROMYCIN A CRS (15 MG)

N-DEMETHYLERYTHROMYCIN A CRS (15 MG)

992-62-1

DISCOVER
DESOXYCORTONE ACETATE CRS (100 MG)

DESOXYCORTONE ACETATE CRS (100 MG)

56-47-3

DISCOVER
DEPTROPINE CITRATE CRS (60 MG)

DEPTROPINE CITRATE CRS (60 MG)

2169-75-7

DISCOVER
Dequalinium chloride CRS, 50mg

Dequalinium chloride CRS, 50mg

522-51-0

DISCOVER
Dequalinium chloride for performance test CRS, 50mg

Dequalinium chloride for performance test CRS, 50mg

522-51-0

DISCOVER
DESACETYLVINBLASTINE CRS (1 MG)

DESACETYLVINBLASTINE CRS (1 MG)

ND

DISCOVER
DESIPRAMINE HYDROCHLORIDE CRS(100 MG)

DESIPRAMINE HYDROCHLORIDE CRS(100 MG)

58-28-6

DISCOVER
DESLANOSIDE CRS (160 MG)

DESLANOSIDE CRS (160 MG)

17598-65-1

DISCOVER
Desmethylmetrifonate CRS, 25mg

Desmethylmetrifonate CRS, 25mg

NA

DISCOVER
DESMOPRESSIN CRS (1 MG)

DESMOPRESSIN CRS (1 MG)

62288-83-9

DISCOVER
DETOMIDINE IMPURITY B CRS (20MG)

DETOMIDINE IMPURITY B CRS (20MG)

NA

DISCOVER
Diclofenac sodium

Diclofenac sodium

15307-79-6

DISCOVER